Our initial findings
The initial findings show that more awareness around COPD, including its risk factors and symptoms, is a gap that needs to be filled. Those who have smoked in the past, or currently smoke, and are over 40 years of age are at high-risk of developing COPD and should speak with their healthcare provider. If they are experiencing any of COPD’s, symptoms like shortness of breath, wheezing or heavy phlegm it is even more important that they talk to their doctor. Empowering patients to speak up as soon as symptoms arise can ensure they are not only getting diagnosed better and quickly, but put on the right course of treatment faster. The sooner help arrives the sooner the disease’s progression is slowed.
The final outcomes of Helping the Missing Million, which includes a national and provincial scorecard, will allow The Lung Association to better shape an environment that will support improved diagnosis and treatment for those living with COPD.
“We are excited to be partnering with Boehringer Ingelheim on Helping the Missing Million, which will give us more insight into the barriers that are preventing people from being diagnosed with COPD, and once diagnosed, discover what the challenges are in getting them the best treatment possible.” – George Habib, President & CEO, The Lung Association – Ontario.
“We are pleased to partner with The Lung Association on this important initiative – which will help us to work toward the shared goal of ensuring people with COPD have the right tools to be diagnosed and treated quickly and effectively. These research findings will help us to identify barriers to optimal COPD care for patients, and together with policy-makers, we can create an action plan that ensures the best outcomes for the patient – who is at the center of all that we do.” – Richard Mole, President & CEO, Boehringer Ingelheim (Canada) Ltd.
“I am thrilled to see work being done to better understand what we can do to better diagnose and treat those living with COPD. Lack of awareness and timely diagnosis are big concerns preventing some with COPD from getting the treatment they need to slow the progression of this disease. It is great to see this is being addressed.” – Dr. Andrea Gershon, Scientist, Sunnybrook Health Sciences Centre.